共 50 条
- [31] Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical studyIMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (07)Onodera, MasafumiUchiyama, ToruAriga, TadashiYamada, MasafumiMiyamura, TakakoArizono, HironoriMorio, Tomohiro
- [32] Safety of the Herbal Medicine SH003 in Patients With Solid Cancer: A Multi-Center, Single-Arm, Open-Label, Dose-Escalation Phase I StudyINTEGRATIVE CANCER THERAPIES, 2024, 23Cheon, ChunhooLee, Hyun WooSym, Sun JinKo, Seong-Gyu
- [33] Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 studyLANCET, 2024, 403 (10427): : 645 - 656Ozen, AhmetChongsrisawat, VoranushSefer, Asena PinarKolukisa, BurcuJalbert, Jessica J.Meagher, Karoline A.Brackin, TaylorFeldman, Hagit BarisBaris, SafaKarakoc-Aydiner, ElifErgelen, RabiaFuss, Ivan J.Moorman, HeatherSuratannon, NarissaraSuphapeetiporn, KanyaPerlee, LorahHarari, Olivier A.Yancopoulos, GeorgeLenardo, Michael J.
- [34] INFLIXIMAB THERAPY FOR NEUROLOGICAL, VASCULAR, AND INTESTINAL INVOLVEMENT IN BEHCET'S DISEASE: EFFICACY, SAFETY, AND PHARMACOKINETICS IN A MULTI-CENTER, PROSPECTIVE, OPEN-LABEL, SINGLE-ARM PHASE 3 STUDYCLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (06) : S148 - S149Ishigatsubo, Y.Hirohata, S.Kikuchi, H.Tateishi, U.Sato, N.Ozaki, K.Kondo, K.Hibi, T.
- [35] Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trialCONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2020, 19Frye, Bjoern C.Rump, Ina CarolineUhlmann, AnnetteSchubach, FabianIhorst, GabrieleGrimbacher, BodoZissel, GernotQuernheim, Joachim Mueller
- [36] Efficacy and safety of eribulin plus gemcitabine in second-line or beyond for patients with HER2-negative metastatic breast cancer: A multi-center, open-label, single-arm, phase II studyJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Peng, PeijianXu, XiaoluZhong, JincaiLin, HongWang, HongYe, Jin-HuiDu, CaiwenWang, Zhi-HuiYu, GengshengZou, GuorongOuyang, JieWang, Yong-XiaLi, Lu-ZhenXu, FeiCui, Shi-En
- [37] Evaluating the Efficacy and Safety of Silodosin on Nocturia in Patients With Benign Prostatic Hyperplasia: A Multicenter, Prospective, Open-label, Single-arm, Phase IV TrialUROLOGY, 2018, 121 : 153 - 157Cho, Kang JunLee, Jeong ZooSong, Yun SeobChoi, Jong BoKim, Dae KyungKim, Yong TaeKim, Joon Chul
- [38] An Open-Label, Multi-Center, Prospective, Interventional, Clinical Study to Evaluate the Efficacy and Safety of Ayuvigo Forte Capsules in Patients Suffering from OligospermiaPHARMACOGNOSY RESEARCH, 2019, 11 (03): : 290 - 294Tamoli, Sanjay M.Mundhe, Narendra B.Deshmukh, Devdatta A.Pande, Shishir PurushottamKamde, Rahul RamkrushnaKumbhar, Vidyadhar S.Upasani, Sachin AnilMahadik, Swapnali B.
- [39] Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurityBMJ OPEN, 2021, 11 (07):Arima, MitsuruInoue, HirosukeNakao, ShintaroMisumi, AkikoSuzuki, MayaMatsushita, ItsukaAraki, ShunsukeYamashiro, ChiemiTakahashi, KazumasaOchiai, MasayukiYoshida, NorikoHirose, MasayukiKishimoto, JunjiTodaka, KojiHasegawa, ShunjiKimura, KazuhiroKusuhara, KoichiKondo, HiroyukiOhga, ShouichiSonoda, Koh-Hei
- [40] Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Zimmer, LisaEigentler, Thomas K.Vaubel, Julia-MarianneMohr, PeterJradi, ZeinabKiecker, FelixUtikal, JochenBerking, CarolaKaempgen, EckhartHauschild, AxelDippel, EdgarRompel, RainerFluck, MichaelStadler, RudolfHerbst, RudolfTerheyden, PatrickGarbe, ClausLoquai, CarmenSchadendorf, Dirk